Progression and disruption of advanced atherosclerotic plaques in murine models. 2008

Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98109, USA. ssmjm@u.washington.edu

The innominate artery is a predilection site for atherosclerotic lesion formation in hyperlipidemic mice. The lesions at this site in chow-fed apo E-/- mice progress from fatty streaks through stages that include atheroma with large necrotic areas, fibro-fatty nodules containing chondrocyte-like cells and highly calcified, acellular plaques. The advanced lesions in the innominate arteries of the apo E-/- mice exhibit a reproducible frequency of intra-plaque hemorrhage that occurs primarily as a result of fissures through lateral fatty streaks that form adjacent to or on top of the established plaques. However, this plaque disruption is not equivalent to plaque rupture in human lesions where there is rupture of well formed fibrous caps. The plaque disruption in the lesions of the chow-fed apo E-/- mice also do not lead to formation of occlusive thrombi, the predominant marker of plaque rupture in humans. Thus, although the lesions in the innominate arteries of hyperlipidemic mice progress to very advanced stages of the disease, they are not, in our opinion a model in which to study the mechanisms of plaque rupture in humans. The advanced lesions in the innominate arteries of the apo E-/- mice may however be adequate models for studying vascular fibrosis and calcification.

UI MeSH Term Description Entries
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
August 2007, Journal of the American Society of Nephrology : JASN,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
January 1999, Revista de neurologia,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
February 1961, Connecticut medicine,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
May 1979, Artery,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
September 2011, Journal of biomechanics,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
April 2006, Arteriosclerosis, thrombosis, and vascular biology,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
March 2008, Current drug targets,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
January 2017, PloS one,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
March 2006, Arteriosclerosis, thrombosis, and vascular biology,
Michael E Rosenfeld, and Michelle M Averill, and Brian J Bennett, and Stephen M Schwartz
May 2016, Journal of clinical and diagnostic research : JCDR,
Copied contents to your clipboard!